|
Name |
19,20-epoxycytochalasins C
|
Molecular Formula | C30H37NO7 | |
IUPAC Name* |
(18-benzyl-6,13-dihydroxy-6,8,14,15-tetramethyl-7,20-dioxo-4-oxa-19-azatetracyclo[10.7.0.01,17.03,5]nonadeca-10,14-dien-2-yl)acetate
|
|
SMILES |
CC(=O)OC1C2OC2C(C)(O)C(=O)C(C)CC=CC2C(O)C(C)=C(C)C3C(Cc4ccccc4)NC(=O)C213
|
|
InChI |
InChI=1S/C30H37NO7/c1-15-10-9-13-20-23(33)17(3)16(2)22-21(14-19-11-7-6-8-12-19)31-28(35)30(20,22)27(37-18(4)32)24-26(38-24)29(5,36)25(15)34/h6-9,11-13,15,20-24,26-27,33,36H,10,14H2,1-5H3,(H,31,35)/b13-9+/t15-,20-,21-,22-,23+,24+,26+,27+,29-,30-/m0/s1
|
|
InChIKey |
ZOSGFLUFAVFHCM-OVLWGNJGSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 523.63 | ALogp: | 2.3 |
HBD: | 3 | HBA: | 7 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 125.5 | Aromatic Rings: | 5 |
Heavy Atoms: | 38 | QED Weighted: | 0.316 |
Caco-2 Permeability: | -5.135 | MDCK Permeability: | 0.00005440 |
Pgp-inhibitor: | 0.953 | Pgp-substrate: | 0.992 |
Human Intestinal Absorption (HIA): | 0.169 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 0.027 |
Blood-Brain-Barrier Penetration (BBB): | 0.545 | Plasma Protein Binding (PPB): | 93.14% |
Volume Distribution (VD): | 2.066 | Fu: | 8.03% |
CYP1A2-inhibitor: | 0.01 | CYP1A2-substrate: | 0.091 |
CYP2C19-inhibitor: | 0.063 | CYP2C19-substrate: | 0.449 |
CYP2C9-inhibitor: | 0.032 | CYP2C9-substrate: | 0.069 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.134 |
CYP3A4-inhibitor: | 0.759 | CYP3A4-substrate: | 0.473 |
Clearance (CL): | 8.88 | Half-life (T1/2): | 0.026 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.662 |
Drug-inuced Liver Injury (DILI): | 0.894 | AMES Toxicity: | 0.024 |
Rat Oral Acute Toxicity: | 0.876 | Maximum Recommended Daily Dose: | 0.215 |
Skin Sensitization: | 0.022 | Carcinogencity: | 0.085 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.248 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
D0V3ZA | 0.268 | ||||||
D0SP3D | 0.267 | ||||||
D01TSI | 0.261 | ||||||
D09NNH | 0.261 | ||||||
D0O5WP | 0.261 | ||||||
D0W7RJ | 0.255 | ||||||
D0D4YZ | 0.255 | ||||||
D06CWH | 0.253 | ||||||
D0C4RB | 0.250 | ||||||
D02HSB | 0.248 |